Functions and effects of mavacamten capsules

Mavacamten capsule is a new type of cardiac myosin inhibitor. It is mainly used to treat obstructive hypertrophic cardiomyopathy (HCM). This disease often causes excessive thickening of the myocardium, affects the normal function of the heart, and then causes a series of cardiovascular diseases. The main function of Mavaceta is to reduce the obstruction of the left ventricular outflow tract and improve the blood flow and overall function of the heart by selectively regulating the force of myocardial contraction.

The mechanism of action of Mavaceta is mainly to target myosin in myocardial cells and inhibit their excessive contraction. Under normal circumstances, the myocardium produces a certain amount of force every time it contracts, but in patients with HCM, overactivity of myosin may lead to abnormal contraction of the myocardium, causing obstruction. By regulating this process, Mavaceta makes the contraction of the myocardium more balanced and reduces the pressure on the LVOT. This mechanism helps relieve various uncomfortable symptoms caused by patients' overloaded heart, such as difficulty breathing, chest pain, and fatigue.

Clinical studies have shown that patients using Mavacartide often experience significant improvements within a short period of time. After receiving treatment, many patients experience a significant improvement in their quality of life and are able to return to a more active lifestyle. In addition, the use of Mavacartide also reduces the need for other traditional medications, especially for those who do not respond well to beta blockers or calcium channel blockers.

However, the use of Mavacatel also requires careful monitoring, especially regarding cardiac function. Because the drug may cause a decrease in left ventricular ejection fraction (LVEF), doctors often perform periodic echocardiograms during treatment to make sure the patient's heart is healthy. This monitoring can not only detect potential side effects in time, but also adjust the drug dosage according to the patient's specific situation to achieve a personalized treatment plan.

Reference materials:https://bnf.nice.org.uk/drugs/mavacamten/